Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2026(Status and Outlook)
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
The global Clinical Oncology Next Generation Sequencing (NGS) market size was estimated at USD 857.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Clinical Oncology Next Generation Sequencing (NGS) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Clinical Oncology Next Generation Sequencing (NGS) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Clinical Oncology Next Generation Sequencing (NGS) market.
Global Clinical Oncology Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Market Segmentation (by Type)
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market Segmentation (by Application)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Clinical Oncology Next Generation Sequencing (NGS) Market
Overview of the regional outlook of the Clinical Oncology Next Generation Sequencing (NGS) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Oncology Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Clinical Oncology Next Generation Sequencing (NGS), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Clinical Oncology Next Generation Sequencing (NGS) market size was estimated at USD 857.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Clinical Oncology Next Generation Sequencing (NGS) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Clinical Oncology Next Generation Sequencing (NGS) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Clinical Oncology Next Generation Sequencing (NGS) market.
Global Clinical Oncology Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Market Segmentation (by Type)
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market Segmentation (by Application)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Clinical Oncology Next Generation Sequencing (NGS) Market
Overview of the regional outlook of the Clinical Oncology Next Generation Sequencing (NGS) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Oncology Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Clinical Oncology Next Generation Sequencing (NGS), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Product Life Cycle
3.3 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2020-2025)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2020-2025)
3.5 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.8.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Clinical Oncology Next Generation Sequencing (NGS) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Clinical Oncology Next Generation Sequencing (NGS) Market
5.7 ESG Ratings of Leading Companies
6 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2020-2025)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2020-2025)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2020-2025)
7 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2020-2025)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2020-2025)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
8 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SALES BY REGION
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.3 North America
8.3.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.4.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.5.2 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.6.2 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.7.2 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET PRODUCTION BY REGION
9.1 Global Production of Clinical Oncology Next Generation Sequencing (NGS) by Region(2020-2025)
9.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2020-2025)
9.3 Global Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Clinical Oncology Next Generation Sequencing (NGS) Production
9.4.1 North America Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Clinical Oncology Next Generation Sequencing (NGS) Production
9.5.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.5.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Clinical Oncology Next Generation Sequencing (NGS) Production (2020-2025)
9.6.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.6.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Clinical Oncology Next Generation Sequencing (NGS) Production (2020-2025)
9.7.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.7.2 China Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Agilent Technologies
10.3.1 Agilent Technologies Basic Information
10.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.3.4 Agilent Technologies Business Overview
10.3.5 Agilent Technologies SWOT Analysis
10.3.6 Agilent Technologies Recent Developments
10.4 Knome
10.4.1 Knome Basic Information
10.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.4.4 Knome Business Overview
10.4.5 Knome Recent Developments
10.5 Genomatix Software
10.5.1 Genomatix Software Basic Information
10.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.5.4 Genomatix Software Business Overview
10.5.5 Genomatix Software Recent Developments
10.6 GATC Biotech
10.6.1 GATC Biotech Basic Information
10.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.6.4 GATC Biotech Business Overview
10.6.5 GATC Biotech Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Basic Information
10.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Macrogen
10.8.1 Macrogen Basic Information
10.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.8.4 Macrogen Business Overview
10.8.5 Macrogen Recent Developments
10.9 Life Technologies
10.9.1 Life Technologies Basic Information
10.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.9.4 Life Technologies Business Overview
10.9.5 Life Technologies Recent Developments
10.10 DNASTAR
10.10.1 DNASTAR Basic Information
10.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.10.4 DNASTAR Business Overview
10.10.5 DNASTAR Recent Developments
10.11 Exosome Diagnostics
10.11.1 Exosome Diagnostics Basic Information
10.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.11.4 Exosome Diagnostics Business Overview
10.11.5 Exosome Diagnostics Recent Developments
10.12 Biomatters
10.12.1 Biomatters Basic Information
10.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.12.4 Biomatters Business Overview
10.12.5 Biomatters Recent Developments
10.13 CLC Bio
10.13.1 CLC Bio Basic Information
10.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.13.4 CLC Bio Business Overview
10.13.5 CLC Bio Recent Developments
10.14 BGI
10.14.1 BGI Basic Information
10.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.14.4 BGI Business Overview
10.14.5 BGI Recent Developments
10.15 Qiagen
10.15.1 Qiagen Basic Information
10.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.15.4 Qiagen Business Overview
10.15.5 Qiagen Recent Developments
10.16 Perkin Elmer
10.16.1 Perkin Elmer Basic Information
10.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.16.4 Perkin Elmer Business Overview
10.16.5 Perkin Elmer Recent Developments
10.17 Pacific Bioscience
10.17.1 Pacific Bioscience Basic Information
10.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.17.4 Pacific Bioscience Business Overview
10.17.5 Pacific Bioscience Recent Developments
10.18 Partek
10.18.1 Partek Basic Information
10.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.18.4 Partek Business Overview
10.18.5 Partek Recent Developments
10.19 GnuBIO
10.19.1 GnuBIO Basic Information
10.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.19.4 GnuBIO Business Overview
10.19.5 GnuBIO Recent Developments
10.20 Foundation Medicine
10.20.1 Foundation Medicine Basic Information
10.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.20.4 Foundation Medicine Business Overview
10.20.5 Foundation Medicine Recent Developments
10.21 Paradigm
10.21.1 Paradigm Basic Information
10.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.21.4 Paradigm Business Overview
10.21.5 Paradigm Recent Developments
10.22 Caris Life Sciences
10.22.1 Caris Life Sciences Basic Information
10.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.22.4 Caris Life Sciences Business Overview
10.22.5 Caris Life Sciences Recent Developments
10.23 Myriad Genetics
10.23.1 Myriad Genetics Basic Information
10.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.23.4 Myriad Genetics Business Overview
10.23.5 Myriad Genetics Recent Developments
11 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
11.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2026-2035)
12.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2026-2035)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2026-2035)
12.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
12.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Product Life Cycle
3.3 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2020-2025)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2020-2025)
3.5 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.8.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Clinical Oncology Next Generation Sequencing (NGS) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Clinical Oncology Next Generation Sequencing (NGS) Market
5.7 ESG Ratings of Leading Companies
6 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2020-2025)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2020-2025)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2020-2025)
7 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2020-2025)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2020-2025)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
8 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SALES BY REGION
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.3 North America
8.3.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.4.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.5.2 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.6.2 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.7.2 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET PRODUCTION BY REGION
9.1 Global Production of Clinical Oncology Next Generation Sequencing (NGS) by Region(2020-2025)
9.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2020-2025)
9.3 Global Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Clinical Oncology Next Generation Sequencing (NGS) Production
9.4.1 North America Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Clinical Oncology Next Generation Sequencing (NGS) Production
9.5.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.5.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Clinical Oncology Next Generation Sequencing (NGS) Production (2020-2025)
9.6.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.6.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Clinical Oncology Next Generation Sequencing (NGS) Production (2020-2025)
9.7.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2020-2025)
9.7.2 China Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Agilent Technologies
10.3.1 Agilent Technologies Basic Information
10.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.3.4 Agilent Technologies Business Overview
10.3.5 Agilent Technologies SWOT Analysis
10.3.6 Agilent Technologies Recent Developments
10.4 Knome
10.4.1 Knome Basic Information
10.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.4.4 Knome Business Overview
10.4.5 Knome Recent Developments
10.5 Genomatix Software
10.5.1 Genomatix Software Basic Information
10.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.5.4 Genomatix Software Business Overview
10.5.5 Genomatix Software Recent Developments
10.6 GATC Biotech
10.6.1 GATC Biotech Basic Information
10.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.6.4 GATC Biotech Business Overview
10.6.5 GATC Biotech Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Basic Information
10.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Macrogen
10.8.1 Macrogen Basic Information
10.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.8.4 Macrogen Business Overview
10.8.5 Macrogen Recent Developments
10.9 Life Technologies
10.9.1 Life Technologies Basic Information
10.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.9.4 Life Technologies Business Overview
10.9.5 Life Technologies Recent Developments
10.10 DNASTAR
10.10.1 DNASTAR Basic Information
10.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.10.4 DNASTAR Business Overview
10.10.5 DNASTAR Recent Developments
10.11 Exosome Diagnostics
10.11.1 Exosome Diagnostics Basic Information
10.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.11.4 Exosome Diagnostics Business Overview
10.11.5 Exosome Diagnostics Recent Developments
10.12 Biomatters
10.12.1 Biomatters Basic Information
10.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.12.4 Biomatters Business Overview
10.12.5 Biomatters Recent Developments
10.13 CLC Bio
10.13.1 CLC Bio Basic Information
10.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.13.4 CLC Bio Business Overview
10.13.5 CLC Bio Recent Developments
10.14 BGI
10.14.1 BGI Basic Information
10.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.14.4 BGI Business Overview
10.14.5 BGI Recent Developments
10.15 Qiagen
10.15.1 Qiagen Basic Information
10.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.15.4 Qiagen Business Overview
10.15.5 Qiagen Recent Developments
10.16 Perkin Elmer
10.16.1 Perkin Elmer Basic Information
10.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.16.4 Perkin Elmer Business Overview
10.16.5 Perkin Elmer Recent Developments
10.17 Pacific Bioscience
10.17.1 Pacific Bioscience Basic Information
10.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.17.4 Pacific Bioscience Business Overview
10.17.5 Pacific Bioscience Recent Developments
10.18 Partek
10.18.1 Partek Basic Information
10.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.18.4 Partek Business Overview
10.18.5 Partek Recent Developments
10.19 GnuBIO
10.19.1 GnuBIO Basic Information
10.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.19.4 GnuBIO Business Overview
10.19.5 GnuBIO Recent Developments
10.20 Foundation Medicine
10.20.1 Foundation Medicine Basic Information
10.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.20.4 Foundation Medicine Business Overview
10.20.5 Foundation Medicine Recent Developments
10.21 Paradigm
10.21.1 Paradigm Basic Information
10.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.21.4 Paradigm Business Overview
10.21.5 Paradigm Recent Developments
10.22 Caris Life Sciences
10.22.1 Caris Life Sciences Basic Information
10.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.22.4 Caris Life Sciences Business Overview
10.22.5 Caris Life Sciences Recent Developments
10.23 Myriad Genetics
10.23.1 Myriad Genetics Basic Information
10.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.23.4 Myriad Genetics Business Overview
10.23.5 Myriad Genetics Recent Developments
11 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
11.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2026-2035)
12.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2026-2035)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2026-2035)
12.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
12.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 5. Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2025)
Table 11. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Type (2020-2025)
Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2020-2025)
Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Type (2020-2025)
Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2020-2025)
Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 34. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 35. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2020-2025) & (K Units)
Table 36. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2020-2025)
Table 37. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2020-2025)
Table 39. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
Table 40. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 41. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2020-2025)
Table 42. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025)
Table 44. North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 45. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 51. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) by Region(2020-2025)
Table 55. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2020-2025)
Table 57. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 64. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 70. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Agilent Technologies Basic Information
Table 75. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 76. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies SWOT Analysis
Table 79. Agilent Technologies Recent Developments
Table 80. Knome Basic Information
Table 81. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 82. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Knome Business Overview
Table 84. Knome Recent Developments
Table 85. Genomatix Software Basic Information
Table 86. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 87. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Genomatix Software Business Overview
Table 89. Genomatix Software Recent Developments
Table 90. GATC Biotech Basic Information
Table 91. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 92. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GATC Biotech Business Overview
Table 94. GATC Biotech Recent Developments
Table 95. Oxford Nanopore Technologies Basic Information
Table 96. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 97. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Oxford Nanopore Technologies Business Overview
Table 99. Oxford Nanopore Technologies Recent Developments
Table 100. Macrogen Basic Information
Table 101. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 102. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Macrogen Business Overview
Table 104. Macrogen Recent Developments
Table 105. Life Technologies Basic Information
Table 106. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 107. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Life Technologies Business Overview
Table 109. Life Technologies Recent Developments
Table 110. DNASTAR Basic Information
Table 111. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 112. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. DNASTAR Business Overview
Table 114. DNASTAR Recent Developments
Table 115. Exosome Diagnostics Basic Information
Table 116. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 117. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Exosome Diagnostics Business Overview
Table 119. Exosome Diagnostics Recent Developments
Table 120. Biomatters Basic Information
Table 121. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 122. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Biomatters Business Overview
Table 124. Biomatters Recent Developments
Table 125. CLC Bio Basic Information
Table 126. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 127. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. CLC Bio Business Overview
Table 129. CLC Bio Recent Developments
Table 130. BGI Basic Information
Table 131. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 132. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BGI Business Overview
Table 134. BGI Recent Developments
Table 135. Qiagen Basic Information
Table 136. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 137. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Qiagen Business Overview
Table 139. Qiagen Recent Developments
Table 140. Perkin Elmer Basic Information
Table 141. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 142. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Perkin Elmer Business Overview
Table 144. Perkin Elmer Recent Developments
Table 145. Pacific Bioscience Basic Information
Table 146. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 147. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Pacific Bioscience Business Overview
Table 149. Pacific Bioscience Recent Developments
Table 150. Partek Basic Information
Table 151. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 152. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Partek Business Overview
Table 154. Partek Recent Developments
Table 155. GnuBIO Basic Information
Table 156. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 157. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. GnuBIO Business Overview
Table 159. GnuBIO Recent Developments
Table 160. Foundation Medicine Basic Information
Table 161. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 162. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Foundation Medicine Business Overview
Table 164. Foundation Medicine Recent Developments
Table 165. Paradigm Basic Information
Table 166. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 167. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Paradigm Business Overview
Table 169. Paradigm Recent Developments
Table 170. Caris Life Sciences Basic Information
Table 171. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 172. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Caris Life Sciences Business Overview
Table 174. Caris Life Sciences Recent Developments
Table 175. Myriad Genetics Basic Information
Table 176. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 177. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Myriad Genetics Business Overview
Table 179. Myriad Genetics Recent Developments
Table 180. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2026-2035) & (K Units)
Table 181. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 183. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 185. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2026-2035) & (K Units)
Table 187. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 189. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Type (2026-2035) & (K Units)
Table 193. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Clinical Oncology Next Generation Sequencing (NGS) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 195. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2026-2035)
Table 196. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 5. Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2025)
Table 11. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Type (2020-2025)
Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2020-2025)
Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Type (2020-2025)
Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2020-2025)
Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 34. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 35. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2020-2025) & (K Units)
Table 36. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2020-2025)
Table 37. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2020-2025)
Table 39. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
Table 40. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 41. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2020-2025)
Table 42. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025)
Table 44. North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 45. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2020-2025) & (K Units)
Table 51. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) by Region(2020-2025)
Table 55. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2020-2025)
Table 57. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 64. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 70. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Agilent Technologies Basic Information
Table 75. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 76. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies SWOT Analysis
Table 79. Agilent Technologies Recent Developments
Table 80. Knome Basic Information
Table 81. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 82. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Knome Business Overview
Table 84. Knome Recent Developments
Table 85. Genomatix Software Basic Information
Table 86. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 87. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Genomatix Software Business Overview
Table 89. Genomatix Software Recent Developments
Table 90. GATC Biotech Basic Information
Table 91. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 92. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GATC Biotech Business Overview
Table 94. GATC Biotech Recent Developments
Table 95. Oxford Nanopore Technologies Basic Information
Table 96. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 97. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Oxford Nanopore Technologies Business Overview
Table 99. Oxford Nanopore Technologies Recent Developments
Table 100. Macrogen Basic Information
Table 101. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 102. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Macrogen Business Overview
Table 104. Macrogen Recent Developments
Table 105. Life Technologies Basic Information
Table 106. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 107. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Life Technologies Business Overview
Table 109. Life Technologies Recent Developments
Table 110. DNASTAR Basic Information
Table 111. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 112. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. DNASTAR Business Overview
Table 114. DNASTAR Recent Developments
Table 115. Exosome Diagnostics Basic Information
Table 116. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 117. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Exosome Diagnostics Business Overview
Table 119. Exosome Diagnostics Recent Developments
Table 120. Biomatters Basic Information
Table 121. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 122. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Biomatters Business Overview
Table 124. Biomatters Recent Developments
Table 125. CLC Bio Basic Information
Table 126. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 127. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. CLC Bio Business Overview
Table 129. CLC Bio Recent Developments
Table 130. BGI Basic Information
Table 131. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 132. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BGI Business Overview
Table 134. BGI Recent Developments
Table 135. Qiagen Basic Information
Table 136. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 137. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Qiagen Business Overview
Table 139. Qiagen Recent Developments
Table 140. Perkin Elmer Basic Information
Table 141. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 142. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Perkin Elmer Business Overview
Table 144. Perkin Elmer Recent Developments
Table 145. Pacific Bioscience Basic Information
Table 146. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 147. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Pacific Bioscience Business Overview
Table 149. Pacific Bioscience Recent Developments
Table 150. Partek Basic Information
Table 151. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 152. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Partek Business Overview
Table 154. Partek Recent Developments
Table 155. GnuBIO Basic Information
Table 156. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 157. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. GnuBIO Business Overview
Table 159. GnuBIO Recent Developments
Table 160. Foundation Medicine Basic Information
Table 161. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 162. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Foundation Medicine Business Overview
Table 164. Foundation Medicine Recent Developments
Table 165. Paradigm Basic Information
Table 166. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 167. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Paradigm Business Overview
Table 169. Paradigm Recent Developments
Table 170. Caris Life Sciences Basic Information
Table 171. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 172. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Caris Life Sciences Business Overview
Table 174. Caris Life Sciences Recent Developments
Table 175. Myriad Genetics Basic Information
Table 176. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 177. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Myriad Genetics Business Overview
Table 179. Myriad Genetics Recent Developments
Table 180. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2026-2035) & (K Units)
Table 181. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 183. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 185. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2026-2035) & (K Units)
Table 187. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (K Units)
Table 189. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Type (2026-2035) & (K Units)
Table 193. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Clinical Oncology Next Generation Sequencing (NGS) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 195. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2026-2035)
Table 196. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Clinical Oncology Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD), 2025-2035
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) (2020-2035)
Figure 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Product Life Cycle
Figure 13. Clinical Oncology Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2025
Figure 14. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2025
Figure 15. Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2025
Figure 18. Industry Chain Map of Clinical Oncology Next Generation Sequencing (NGS)
Figure 19. Global Clinical Oncology Next Generation Sequencing (NGS) Market PEST Analysis
Figure 20. Global Clinical Oncology Next Generation Sequencing (NGS) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type
Figure 27. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2020-2025)
Figure 28. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2025
Figure 29. Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2020-2025)
Figure 30. Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application
Figure 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2020-2025)
Figure 34. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application in 2025
Figure 35. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2020-2025)
Figure 36. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2025
Figure 37. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2020-2025)
Figure 39. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025)
Figure 40. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 43. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 45. U.S. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 53. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 55. Germany Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region in 2024
Figure 68. China Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 79. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 80. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (M USD)
Figure 81. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 82. Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region in 2024
Figure 92. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Clinical Oncology Next Generation Sequencing (NGS) Production Market Share by Region (2020-2025)
Figure 103. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2026-2035)
Figure 111. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Application (2026-2035)
Figure 112. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Clinical Oncology Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD), 2025-2035
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) (2020-2035)
Figure 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Product Life Cycle
Figure 13. Clinical Oncology Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2025
Figure 14. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2025
Figure 15. Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2025
Figure 18. Industry Chain Map of Clinical Oncology Next Generation Sequencing (NGS)
Figure 19. Global Clinical Oncology Next Generation Sequencing (NGS) Market PEST Analysis
Figure 20. Global Clinical Oncology Next Generation Sequencing (NGS) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type
Figure 27. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2020-2025)
Figure 28. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2025
Figure 29. Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2020-2025)
Figure 30. Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application
Figure 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2020-2025)
Figure 34. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application in 2025
Figure 35. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2020-2025)
Figure 36. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2025
Figure 37. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2020-2025)
Figure 39. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2020-2025)
Figure 40. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 43. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 45. U.S. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 53. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 55. Germany Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region in 2024
Figure 68. China Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 79. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2024
Figure 80. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (M USD)
Figure 81. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country in 2024
Figure 82. Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region in 2024
Figure 92. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Clinical Oncology Next Generation Sequencing (NGS) Production Market Share by Region (2020-2025)
Figure 103. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2026-2035)
Figure 111. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Application (2026-2035)
Figure 112. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2026-2035)
